Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study

por Chang, Anne Lynn S., Tran, Duy C., Cannon, John G. D., Li, Shufeng, Jeng, Mark, Patel, Roma, Van der Bokke, Lindsay, Pague, Alana, Brotherton, Richard, Rieger, Kerri E., Satpathy, Ansuman T., Yost, Kathryn E., Reddy, Sunil, Sarin, Kavita, Colevas, A. Dimitrios
Publicado 2018